Medication info
Ezetimibe Tablets (Ezetimibe)

Ezetimibe Tablets (Ezetimibe)

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Organon Korea Co., Ltd.
Appearance
White to off-white rectangular tablets with '414' engraved on one side.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 200410337 · Approved 2004.07.14 · Insurance code 073100020

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who takes it
Adults
Adult dose
A standard cholesterol-lowering diet should be continued during treatment with this medication. The recommended dose is 10 mg once daily, taken with or without food. When this medication is administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medication at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medication concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medication is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160 mg once daily or 200 mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with bile acid sequestrants This medication should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Ingredients

Importer
Organon Korea Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • elevated low-density lipoprotein cholesterol
  • elevated apolipoprotein B
  • mixed dyslipidemia
  • elevated non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • elevated sitosterol
  • elevated campesterol
View approved original text

This medicine is used as an adjunct to diet for lowering total cholesterol and bad cholesterol (LDL cholesterol) and apolipoprotein B levels in patients with primary hypercholesterolemia. It is also useful for patients with mixed dyslipidemia and can enhance the effect when used in combination with fenofibrate. For patients with homozygous familial hypercholesterolemia or homozygous sitosterolemia, this medicine can be used alone or in conjunction with other treatments. It should be used in conjunction with an appropriate diet, and it is important to exclude and treat other secondary causes. Additionally, lipid levels should be monitored before and after treatment to assess the patient's condition. This medicine is effective in improving hypercholesterolemia and related dyslipidemic conditions.

How to take

Adult dose

A standard cholesterol-lowering diet should be continued during treatment with this medication. The recommended dose is 10 mg once daily, taken with or without food. When this medication is administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), start this medication at the recommended initial dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this medication concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this medication is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160 mg once daily or 200 mg once daily (see Precautions for Use, 4. General Precautions). Use in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medication is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Caution). Use in patients with renal impairment No dosage adjustment is necessary in patients with renal impairment. Use in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with bile acid sequestrants This medication should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Precautions

This medicine should not be used by patients allergic to its components. It is advisable not to take this medicine with certain lipid-lowering agents in patients with liver problems or abnormal liver enzyme levels. Women who are pregnant or breastfeeding should be cautious, as the combination of this medicine with certain lipid-lowering agents is prohibited. This medicine is not recommended for patients with moderate to severe liver impairment, and regular liver function tests should be performed. This medicine may cause muscle-related side effects such as myalgia or muscle weakness, so if these symptoms occur, patients should consult a physician immediately. Patients with severely impaired kidney function should also use this medicine with caution, and dosage adjustments may be necessary if required. This medicine may interact with certain drugs, so it is essential to inform the doctor or pharmacist if other medications are being taken. It is not recommended for children, especially those under 6 years of age, and should be used in children aged 6 and older according to a physician's directive. Elderly patients can use this medicine but should do so with caution considering the potential for age-related side effects. In cases of overdose, there are no specific antidotes, and appropriate treatment should be obtained based on symptoms, and the medication should be kept out of reach of children.

Side effects

  • Fatigue
  • abdominal pain
  • diarrhea
  • viral infection
  • pharyngitis
  • sinusitis
  • joint pain
  • low back pain
  • cough
  • chest pain
Show 65 more
  • dizziness
  • headache
  • constipation
  • bloating
  • nausea
  • elevation of AST
  • elevation of ALT
  • myalgia
  • myopathy
  • rhabdomyolysis
  • elevation of aminotransferase levels
  • gallbladder-related adverse reactions
  • cholelithiasis
  • cholecystitis
  • anaphylaxis
  • urticaria
  • rash
  • angioedema
  • erythema multiforme
  • thrombocytopenia
  • pancreatitis
  • paresthesia
  • drug reaction with systemic symptoms
  • erythema multiforme
  • drug-induced liver injury
  • chest discomfort
  • edema
  • weakness
  • generalized edema
  • diabetic neuropathy
  • tremors
  • epigastric pain
  • vomiting
  • gastritis
  • dry mouth
  • discomfort in the epigastrium
  • belching
  • gastrointestinal disturbance
  • gastroesophageal reflux disease
  • tongue disorders
  • palpitations
  • congestive heart failure
  • myocardial ischemia
  • flushing
  • phlegm
  • runny nose
  • limb pain
  • diabetes mellitus
  • hypoglycemia
  • anemia
  • splenomegaly
  • urticaria
  • hyperhidrosis
  • pruritus
  • upper respiratory tract infection
  • conjunctival hyperemia
  • renal failure
  • abnormal liver function
  • increased serum creatinine
  • elevated blood pressure
  • increased blood urea
  • elevated serum creatine phosphokinase
  • abnormal liver function tests
  • dyspepsia
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine is sensitive to air and moisture and should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius to preserve its efficacy and safety for an extended period.

Appearance and packaging

Appearance

White to off-white rectangular tablets with '414' engraved on one side.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.